{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-23-001070","form_type":"8-K","ticker":"LCTC","cik":"0001493137","company_name":"Lifeloc Technologies, Inc","filed_at":"2023-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.078808+00:00","generated_at":"2026-06-12T04:06:55.390751+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Lifeloc Q2 2023 net profit $55K vs loss last year; SpinDx beta testing expected in 2023","bullets":["Quarterly revenue $2.280M, up 5% YoY; net profit $55K ($0.02 diluted EPS) vs loss of $(202)K in Q2 2022.","Gross margin improved to 45.7% from 30.4% YoY on price increases, lower depreciation, and easing supply constraints.","R&D spending rising for SpinDx platform; beta testing of saliva THC detection device expected in 2023, commercialization in 2024.","CEO notes production backlog partially satisfied; supply constraints no longer a significant impediment to order flow.","Six-month net profit $1K (breakeven) vs loss of $(346)K in same period of 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-23-001070","json":"https://secwatch.observer/filing/0001079973-23-001070.json","markdown":"https://secwatch.observer/filing/0001079973-23-001070.md","text":"https://secwatch.observer/filing/0001079973-23-001070.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1493137/000107997323001070/0001079973-23-001070-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1493137/000107997323001070/lctc_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T04:06:55.390751+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2014ef8ecbe178aef9017f9c9c13c7345ca0c969","claim":"Lifeloc Technologies, Inc reported the quarter ended June 30, 2023 results: revenue $2.280 million, net income $55 thousand, EPS $0.02 per diluted share.","evidence_excerpt":"Lifeloc posted quarterly net revenue of $2.280 million in the second quarter of 2023, resulting in a quarterly net profit of $55 thousand, or $0.02 per diluted share.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1493137/000107997323001070/0001079973-23-001070-index.htm","confidence":0.98,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended June 30, 2023"},{"label":"Revenue","value":"$2.280 million"},{"label":"Net income","value":"$55 thousand"},{"label":"EPS","value":"$0.02 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}